Pricing database updated August 4, 2026Methodology v1.0How we score →
Compare Providers
Home / Compare / NexLife vs Found
This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.
Disclosure: we may earn a commission if you use certain links on this page. Compensation does not change our published methodology, scoring, or editorial conclusions.
Written by Kim Callender, NP, FNP-BC·Published July 12, 2026·Last reviewed August 4, 2026·Prices verified August 4, 2026·Methodology v1.0
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.

NexLife vs Found: pricing, doses and services compared

Which is better for whom?

NexLife and Found serve different priorities. NexLife: NexLife bundles medication, clinician care, laboratory review, support and expedited shipping into one flat price with n… Found: Found restructured in 2026: the compounded medication is now INCLUDED in the plan price, flat across semaglutide, tirzep… There is no universal winner — the right choice depends on whether you optimize for lowest starter price, flat dose pricing, or bundled clinical services. Figures reflect status as of July 12, 2026.

How do they compare, field by field?

Price comparison — NexLife vs Found, July 12, 2026
$0$47$95$142$189Starting priceHighest-dose price
NexLifeFound

Where a program holds one flat price across doses, its two bars are equal. Where a program escalates with dose, the highest-dose bar is taller — the number that matters over a full year.

NexLife vs Found — side by side, July 12, 2026
FactorNexLifeFound
Starting price$147/mo (microdose) Verified$169/mo (12-month prepaid) Reported — pending verification
Renewal price$186/mo full-dose (12-mo); $215 month-to-month Verified$199 (6-mo); $289 month-to-month Reported — pending verification
Highest-dose priceFlat — no dose-based increase VerifiedFlat across all compounded GLP-1s and all doses Reported — pending verification
Membership$0 VerifiedNone — medication now included Reported — pending verification
LabsLab review included VerifiedFree insurance check Reported — pending verification
ShippingIncluded (expedited) VerifiedIncluded Reported — pending verification
Commitment12-month or month-to-month Verified12-month prepay for the headline rate Reported — pending verification
PharmacyNetwork disclosed: Red Rock, Hallandale, Absolute, Empower, DIRx (licences not yet independently verified by us) VerifiedNot independently verified Reported — pending verification
ClinicianMedical Director: Adam Kennah, MD (NPI 1144260043, provider-supplied) VerifiedClinician network + behavioural coaching Reported — pending verification
StatesAll 50 states, synchronous and asynchronous visits VerifiedPending research Reported — pending verification

Which one wins on each decision factor?

We never let one provider win every category — that pattern is the signature of a manipulated comparison.

Winner by decision factor
Decision factorBetter fit
Lowest advertised starter priceNexLife
Best all-inclusive valueNexLife
Clearest pharmacy disclosureDepends / tie
Best month-to-month flexibilityNexLife

NexLife: who it fits

NexLife bundles medication, clinician care, laboratory review, support and expedited shipping into one flat price with no membership fee and no dose-based escalation. Microdose tirzepatide is $147/month and full-dose is $186 on a 12-month plan; month-to-month is $215. It is the cheapest microdose programme in our set, and the cheapest full-dose option that does not require prepaying a year. Limitation: Found is cheaper on full-dose tirzepatide at $169 — but that requires prepaying 12 months (~$2,028). Oak Longevity is cheaper on semaglutide at $133. NexLife offers no brand pathway and no insurance coordination. Full NexLife review →

Found: who it fits

Found restructured in 2026: the compounded medication is now INCLUDED in the plan price, flat across semaglutide, tirzepatide and liraglutide and across all doses. $169/month on the 12-month prepaid plan makes it the cheapest full-dose compounded tirzepatide in our set. The old $249-medication-plus-$99-membership split is retired. Limitation: The $169 rate requires prepaying twelve months (roughly $2,028 up front). Month-to-month is $289. Found also resells brand Mounjaro and Ozempic at roughly $1,100–$1,199/month — near-retail, when the manufacturers sell them direct for far less. Full Found review →

Frequently asked questions

Is NexLife or Found cheaper?

On starting price: NexLife is $147/mo (microdose) and Found is $169/mo (12-month prepaid). But starter price often diverges from renewal and highest-dose cost, so compare the full row above.

How were these figures verified?

Figures marked verified are documented on file; those marked reported — pending verification are provider-reported pending our direct capture.

Sources

  1. Both providers' pricing and terms pages, captured July 12, 2026.
  2. Our price-normalization methodology.
  3. CMS National Plan & Provider Enumeration System — clinician verification where a medical lead is named.

Spotted an error? Submit a correction.

How the dates on this page work. Manufacturer self-pay prices — NovoCare and LillyDirect — were re-read on the manufacturers’ own published price guides on 4 August 2026. Figures captured from third-party provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row says so. We do not restamp a figure we have not re-read.